CME Group (NASDAQ:CME) had its target price reduced by investment analysts at Deutsche Bank from $220.00 to $214.00 in a report released on Friday. The brokerage currently has a “buy” rating on the financial services provider’s stock. Deutsche Bank’s price objective would suggest a potential upside of 26.07% from the stock’s previous close.

Other research analysts also recently issued reports about the company. Sanford C. Bernstein reissued an “outperform” rating and issued a $210.00 price target on shares of CME Group in a report on Friday, February 15th. Citigroup set a $205.00 price objective on CME Group and gave the company a “buy” rating in a research report on Friday, February 15th. Keefe, Bruyette & Woods restated a “hold” rating and issued a $184.00 price objective on shares of CME Group in a research report on Monday, December 10th. BidaskClub cut CME Group from a “hold” rating to a “sell” rating in a research report on Thursday. Finally, UBS Group cut CME Group from a “buy” rating to a “neutral” rating and boosted their price objective for the company from $185.00 to $204.00 in a research report on Wednesday, November 28th. Two equities research analysts have rated the stock with a sell rating, eight have given a hold rating and seven have assigned a buy rating to the company’s stock. CME Group presently has a consensus rating of “Hold” and a consensus price target of $194.00.

NASDAQ:CME traded up $1.32 during trading hours on Friday, reaching $169.75. The company had a trading volume of 45,473 shares, compared to its average volume of 1,859,918. CME Group has a 1-year low of $153.90 and a 1-year high of $197.08. The company has a market capitalization of $60.12 billion, a PE ratio of 24.88, a PEG ratio of 2.15 and a beta of 0.31. The company has a current ratio of 1.01, a quick ratio of 1.01 and a debt-to-equity ratio of 0.15.

CME Group (NASDAQ:CME) last announced its quarterly earnings results on Thursday, February 14th. The financial services provider reported $1.77 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $1.75 by $0.02. CME Group had a return on equity of 9.85% and a net margin of 45.53%. The company had revenue of $1.24 billion during the quarter, compared to the consensus estimate of $1.22 billion. During the same period in the previous year, the company posted $1.12 earnings per share. CME Group’s revenue for the quarter was up 37.4% on a year-over-year basis. Equities research analysts predict that CME Group will post 7.07 earnings per share for the current fiscal year.

In related news, Director Jeffrey M. Bernacchi sold 10,087 shares of the business’s stock in a transaction that occurred on Tuesday, February 26th. The stock was sold at an average price of $177.94, for a total transaction of $1,794,880.78. Following the completion of the sale, the director now directly owns 42,004 shares in the company, valued at $7,474,191.76. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO John W. Pietrowicz sold 17,960 shares of the business’s stock in a transaction that occurred on Wednesday, January 2nd. The stock was sold at an average price of $186.92, for a total value of $3,357,083.20. Following the sale, the chief financial officer now owns 44,780 shares of the company’s stock, valued at $8,370,277.60. The disclosure for this sale can be found here. Insiders have sold 32,609 shares of company stock valued at $5,984,391 over the last quarter. 0.43% of the stock is owned by company insiders.

Several institutional investors and hedge funds have recently modified their holdings of CME. Sheaff Brock Investment Advisors LLC grew its holdings in CME Group by 0.3% in the 4th quarter. Sheaff Brock Investment Advisors LLC now owns 22,040 shares of the financial services provider’s stock valued at $4,146,000 after buying an additional 60 shares in the last quarter. Dorsey & Whitney Trust CO LLC grew its holdings in CME Group by 1.4% in the 4th quarter. Dorsey & Whitney Trust CO LLC now owns 4,575 shares of the financial services provider’s stock valued at $860,000 after buying an additional 65 shares in the last quarter. Private Trust Co. NA grew its holdings in CME Group by 1.9% in the 4th quarter. Private Trust Co. NA now owns 3,488 shares of the financial services provider’s stock valued at $656,000 after buying an additional 66 shares in the last quarter. Front Barnett Associates LLC grew its holdings in CME Group by 5.4% in the 4th quarter. Front Barnett Associates LLC now owns 1,433 shares of the financial services provider’s stock valued at $267,000 after buying an additional 73 shares in the last quarter. Finally, Ascension Asset Management LLC grew its holdings in CME Group by 0.6% in the 4th quarter. Ascension Asset Management LLC now owns 12,385 shares of the financial services provider’s stock valued at $2,330,000 after buying an additional 75 shares in the last quarter. Hedge funds and other institutional investors own 88.49% of the company’s stock.

CME Group Company Profile

CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products, and metals.

Read More: What is a conference call?

Analyst Recommendations for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.